Skip to main content

Trend of malaria prevalence in Wolkite health center: an implication towards the elimination of malaria in Ethiopia by 2030

Abstract

Background

Malaria is one of the main public health challenges in Ethiopia that hinder the productivity and development of the country. In 2018, Ethiopia is on track to minimize the incidence of malaria by 40% as per its 2020 malaria reduction strategy. Currently, Ethiopia is working to eliminate malaria in 2030 by extending the 2020 strategy. Hence, this study aimed to analyze the trend of malaria prevalence in Wolkite health center, Gurage zone, Southern Central Ethiopia from 2015 to 2018.

Methods

A retrospective study was conducted to determine the prevalence of malaria by reviewing the malaria registration laboratory logbook at Wolkite health center from 2015 to 2018. For all patients, blood films were done for the detection of malaria cases. All the socio-demographic data, year, month and malaria data were collected using a predesigned data collection sheet from January to March, 2019.

Results

From a 121,230 clinically malaria suspected patients, the overall prevalence of microscopically confirmed cases were 8.56% (n = 10,379/121,230). Plasmodium vivax was the most predominant species accounted for 69.7% (n = 7237/10,379) followed by Plasmodium falciparum 29.3% (n = 3044/10,379). Age group > 15 years old were more affected by malaria accounting 54% (n = 5609/10,379) and malaria cases regarding sex were proportional (51.1% of males and 48.3% of female). Among the catchment areas, a higher number of malaria prevalence was recorded in the Wolkite town 66.2% (n = 0.6538/10,379). Higher malaria cases were shown in the season of Spring 29.8% (n = 3096/10,379) while lower cases 20.4% (n = 2123/10,379) were seen in the Winter season.

Conclusion

The prevalence of malaria in Wolkite health center showed a consistent downward trend from the year of 2015–2018. Importantly, the higher prevalence of P. vivax seems overlooked in the study area. Therefore, malaria prevention and control strategy should be reinforced to reduce the prevalence of malaria in the study area.

Background

Despite a rigorous effort done to prevent malaria, it is still a major public health challenge worldwide causing a significant burden of illness and mortality [1]. Globally, an estimated 219 million malaria cases and 435,000 death occurrence have been reported in 2017. African took a higher share from the global malaria burden and Plasmodium falciparum is the most predominant species, accounting for 99.7% [2]. The burden of malaria is more devastating in children and pregnant women [3]. Even though the expanded coverage of malaria prevention and case–control service reduced mortality and morbidity, malaria is a major threat especially to sub Saharan African countries including Ethiopia [4].

Around 68% of the Ethiopian population resides in the area below 2000 m altitude which is considered to be at risk of malaria. Thus, malaria is one of the public health challenges in Ethiopia impede the socio-economic development of the country [4, 5]. The transmission of malaria is highly seasonal throughout the country that depends on altitude and climatic variations [2]. Plasmodium falciparum and Plasmodium vivax are the most dominant malaria parasites in Ethiopia accounting for 60% and 40% of malaria cases respectively [5]. The major responsible vector for malaria transmission in Ethiopia is Anopheles arabiensis however in some other areas A. pharoensis, A. funestus, and A. nili are also responsible for the transmission of malaria [6].

Malaria prevention and control program in Ethiopia is guided by the National Malaria Strategic Plan (NMSP) in line with global Roll Back Malaria (RBM) [4]. The current vector control interventions implemented in Ethiopia include insecticide-treated mosquito nets (ITNs), indoor residual spraying (IRS) and mosquito larval source reduction [7]. As stated in the 2015 malaria indicator survey (MIS), above 70% of households in malaria-endemic areas were protected by ITN or IRS. The national malaria guidelines recommend Artemisinin-based combination therapies (ACTs) for the treatment of uncomplicated malaria caused by P. falciparum and for P. vivax treatment chloroquine remains efficacious in malaria-endemic areas. Whereas, Primaquine is recommended for radical cure of patients with P. vivax in non malarious area, however, to the best of author’s knowledge there was no published data that state the current Primaquine usage in Ethiopia [6, 8].

Ethiopia has recently targeted malaria elimination nationwide in 2030 aligned with the World Health Organization (WHO) Global Technical Strategy (GTS) through intensifying the existing malaria control activities [9]. Presently, Ethiopia is on track to achieve the 2020 milestone by reducing the incidence of malaria by 40% [2]. However, the emergence of insecticide resistance, migrant population, emerging chloroquine resistance for P. vivax, difficulty in control and elimination of P. vivax are the challenging factors for malaria elimination in Ethiopia and worldwide [5, 10].

According to the Gurage zone heath department, a higher prevalence of malaria was recorded in Wolkite, Abshge and Cheha woredas (district) in 2018 [11]. Analyzing the prevalence of malaria trends each year is important for expanding the prevention and control strategy as well as for designing new policies for appropriate intervention that could assist in the elimination of malaria in 2030. Thus, this study aimed to assess the trend of malaria prevalence in Wolkite health center in Gurage zone from 2015 to 2018. The findings may insight stakeholders to revise malaria control strategies in the study area.

Methods

Study area and study population

The study was conducted in Wolkite health center, located in Gurage Zone. Wolkite town is located 158 km southwest of Addis Ababa, the capital city of Ethiopia. Wolkite is the capital city of Gurage Zone that has an average annual temperature of 18.6 °C and an average rainfall of 1244 mm (Fig. 1). The town has an elevation between 1910 and 1935 meters above sea level [12, 13]. Based on the 2007 Census conducted by the Central Statistical Agency of Ethiopia, Wolkite town has a total population of 28,856 of whom 15,068 were males and 13,788 females [14]. Wolkite health center offers diagnosis and treatment for patients that reside in Wolkite town and nearby neighbor woredas like Kebena, Abeshge and others.

Fig. 1
figure 1

Map of the study area

Malaria transmission in Gurage Zone is unstable, seasonal and depends on altitude and rainfall. There are two main seasons for transmission of the disease; September to December, after the heavy summer rains and March to May, after the light rains. As the area is malaria-endemic, those individuals who were febrile and had a body temperature above 380 C, were tested for malaria. Thus, all patient results registered for the last 4 years (2015–2018) in the malaria logbook at Wolkite health center were the study population. The data was collected from the health center from January to March 2019.

Study design

A retrospective study was conducted to determine the trend of malaria prevalence by reviewing the blood film malaria registration laboratory logbook at Wolkite health center Gurage zone, Southern Central Ethiopia from 2015 to 2018.

Data collection and data analysis

A 4-year malaria data were extracted from laboratory logbook by using data collection sheet including year, month, sex, age, residence, total number of BF examined and species type (P. falciparum, P. vivax and mixed infections). In Wolkite health center, microscopy is used as a golden standard to confirm the presence of Plasmodium parasite and species identification. From clinically suspected patients, a capillary blood sample was collected to prepare both thin and thick blood films according to standard WHO protocol. After properly labeled and air-dried in a horizontal position, thin films were fixed with absolute methanol and both thin and thick films were stained with 3% Giemsa solution for 30 min. Then blood films were examined microscopically for parasite using 100× oil immersion. If no parasites were found after examining 100 fields, it was reported as negative [15]. In addition, laboratory technologists/technicians involved in malaria microscopy had 2–13 years of experience and well trained for malaria microscopy at least twice in their career.

After checking the data completeness, it was analyzed using SPSS version 20 software. Descriptive statistics were used to analyze microscopically confirmed malaria cases with year. Specifically, the distribution of malaria species in each year with clinically examined and confirmed cases was summarized using a table. Also, Pearson’s Chi-square test was used to determine the association of Plasmodium species with age group, sex and residence. Malaria prevalence was computed by dividing the number of people who showed infection with Plasmodium species to the total number of people examined from the study population. Graphs were used to depict the overall trend of malaria prevalence and malaria species distribution with residence and season. A P-value < 0.05 was taken as statistically significant.

Results

General characteristics of the Study Population

During the last 4 years, from January 2015 to December 2018, a total of 121,230 patients who were clinically suspected of malaria have been examined for malaria parasites. Of the total patients who requested for blood films, examined blood film, 8.56% (10,379/121,230) were microscopically confirmed for malaria infection which was the overall malaria prevalence. Of these, 5336 (51.1%) were male and 5043 (48.3%) were female. Majority of the study participant was in the > 15 years’ age group and reside in Wolkite town 5609 (54%) and 6555 (62.8%) respectively (Table 1).

Table 1 Socio-demographic distribution among the study population in Wolkite health center from 2015 to 2018

Malaria prevalence at Wolkite health center

Of the total 121,230 clinically malaria suspected patients, the utmost number of confirmed annual malaria cases was reported in 2015 and a minimum in 2018 (Fig. 2). Of the Plasmodium species identified, P. vivax was the most predominant species accounted for 69.7% followed by P. falciparum 29.3% and mixed infection accounted for 0.9% from the confirmed malaria cases (Table 2). In general, consistent reduction of malaria trend was recorded and the slide positivity was 13.5%, 9.8%, 5.5% and 4.1% during the last 4 years from 2015 to 2018 respectively (Fig. 3). All Plasmodium species infections including mixed infection showed a decreasing trend throughout all 4 years. Nevertheless, there was a slight increment in the number of mixed malaria infections in 2018 compared to 2017.

Fig. 2
figure 2

The distribution of confirmed malaria cases by months at Wolkite health center from 2015 to 2018

Table 2 Malaria case distribution in Wolkite health center from 2015–2018
Fig. 3
figure 3

Overall trend of malaria prevalence at Wolkite health center from 2015 to 2018

The annual parasitic incidence (API) cases showed a decreasing trend during the last 4 years (2015–2018) 157, 107, 60 and 35 per 1000 population respectively. Similarly, the API for each species has depicted a similar decreasing pattern. The annual falciparum incidence was 41, 30, 21 and 14 per 1000 population whereas annual vivax incidence was 114, 77, 39 and 21 per 1000 population from 2015 to 2018 respectively (Table 3).

Table 3 Annual Parasite Incidence in Wolkite health center from 2015–2018

Though malaria cases were detected in all age group the highest affected age group was > 15 years old which accounted for 54% (5609/10,379) followed by 5–14 age group 23.5% (2437/10,379) while the least affected age group was < 1 year 4.97% (516/10,379). In all age groups, P. vivax was the most frequently reported species. There was a statistically significant association between Plasmodium species and age groups (P = 0.002). With regard to the sex, males and females were equally infected with a little variation 51.4% and 48.6% respectively. There was no statistical significant association between Plasmodium species and Sex (P = 0.55) (Table 1).

Malaria species distribution among residence at Wolkite health center

Plasmodium vivax was the predominant species in all residence and a higher percentage is accounted in Wolkite town 66.2% (6538/10,379) followed by Abeshge Woreda 25.2% (2934/10379), Kebena 5.9% (607/10,379) and 2.7% (300/10,379) in the other. In the meantime, P. falciparum was significantly higher in all woredas, accounting 55.4%, 35.4%, 5.7%, 3.4% in Wolkite, Abeshge, Kebena, and other respectively (Fig. 4). There was a statistical significant association between Plasmodium species and residence (P < 0.001).

Fig. 4
figure 4

Malaria species distribution among residence at Wolkite health center from 2015 to 2018

Seasonal variation of malaria at Wolkite health center

The prevalence of malaria for the four seasons in Ethiopia was analyzed. During all the 4 years, May and November were the highest blood film examined accounted 9.9% (11,979/121,230) and 9.5% (11,586/121,230) respectively while the lowest was in July 6.7% (8139/121,230). The maximum number of confirmed malaria cases was reported in spring (September, October, and November) and the minimum was reported during winter (December, January, and February) seasons. Plasmodium vivax, P. falciparum and mixed malaria infections were higher in spring and lower during the Winter season (Fig. 5) There was no statistical significant association between Plasmodium species and season (P = 0.23).

Fig. 5
figure 5

Distribution of Plasmodium species in seasons at Wolkite Health center from 2015 to 2018

Discussion

In the present study, the overall microscopically confirmed malaria cases in Wolkite health center was 10,379 (8.56%) from 2015 to 2018. The maximum and minimum confirmed malaria case was reported in 2015 and 2018 respectively. However, the prevalence was lower than reported from other retrospective studies conducted in Adi Arkay health center (36.1%), Serbo health center (43.8%), Halaba special district (9.5%) and Wolaita zone (33.27%) [16,17,18,19]. This variation might be due to climatic and altitude differences. In the previous study, endemic areas of Gurage zone had a good practice of malaria prevention measures accounted for 62% [20]. Moreover, according to 2018 Gurage zone health bureau report, the overall coverage of main malaria interventions, ITNs and IRS, has reached 88% in Gurage zone where Wolkite town accounted 95.6%, Abshge 87%, Kebena 95.5% which attributed for the reduction of malaria incidence [11]. In the study area, P. vivax was the dominant species among the Plasmodium species (69.7%) followed by P. falciparum (29.3%) during the last 4 years. This was similar to reports from Jimma and Butajira area, near the study area [21, 22]. The biological character of the Plasmodium species including the dormant stage of the parasite in the liver causing relapsing attribute to the predominance of P. vivax. In addition, the performance difference of the laboratory personnel regarding malaria species identification might be attributed to increased prevalence. However, despite emerging chloroquine resistance P. vivax has been reported in southern Ethiopia [10], chloroquine is an efficacious drug for the treatment of P. vivax malaria in the study area [23].

Malaria prevalence trend showed consistent reduction during the last 4 consecutive years from 2015 to 2018 which was in agreement with a study reported in Kenya [24]. All Plasmodium species infections including mixed infection showed a decreasing trend throughout all 4 years. With the exception, a slight increment in the number of mixed malaria infection was recorded in 2018 compared to 2017. This shows continuous efforts were done in scaling up malaria prevention and control at the national and local levels. This might highlight the need for continuous efforts to eliminate malaria earlier than its plan.

In the present study, Plasmodium infection was nearly equal with only slight variation among males and females which was comparable with a study conducted in Wolaita zone [19]. This finding was in contrast with the majority of the study done in Ethiopia [25, 26] where males were highly affected by malaria than females. Both males and females are involved in outdoor activities especially males in the agricultural activities and most females travel to town for the market thus, they are exposed to the bite of Anopheles mosquitoes.

Regarding age, the highest affected age group was > 15 years accounted for 54% followed by 5–14 age group 23.5% while the least affected age group was < 1 year in both sexes and the most frequently reported species in all age groups were P. vivax. The highest malaria prevalence in the adult age group obtained was in agreement with other findings reported across Ethiopia [19, 22, 27, 28]. Whereas a finding from Arsi Negelle [29] showed that highly affected age group was 0–5 years followed by 16–20 years old. The reason for this variation might be the majority of the study participants were adults and as this age group is young and productive, they are actively engaged in an agricultural activity that might prone them for an anopheles mosquito bite. In addition, they travel far for schooling which exposes them to the infection.

The prevalence and magnitude of malaria transmission are mainly determined by environmental, climatic and seasonal factors. In highland-fringe areas, like Wolkite town, malaria transmission is seasonal and depends on altitude and rainfall. Thus, higher malaria transmission is recorded after the heavy rain of summer, September to December and the lowest in March to May after the light rains, which agrees with our findings. This was also in agreement with other studies done in the different parts of Ethiopia [26, 28]. Variability of rainfall and temperature in each season affects the availability of breeding habitats for mosquito vectors, the length of mosquito larvae development and the rate of growth of the malaria parasites inside the vector [30].

The distribution of Plasmodium infections across a community varies in a predictable pattern based on age and transmission intensity [31]. A higher prevalence of malaria infection was recorded in Wolkite town followed by Abeshge, Kebena and others. Plasmodium vivax was the predominant species in all residences. This variability in the prevalence of malaria among residences agrees with studies undertaken in Butajira [22], Tanzania [32] and Ghana [33]. This might be due to variation in the intervention of malaria prevention and control activities from one area to another. In the present study, there was a statistically significant association of Plasmodium infection with residence and age group. As Plasmodium infection varies between geographical setting and population, the control strategy must vary according to each area’s local epidemiology [31]. Thus, the national malaria control program should enhance the access of malaria prevention to high-risk populations and prioritize high-risk areas based on stratification.

Limitation of the study was poor management of patient data, 46 data were excluded from the study and only 4-year data were available during the data collection time. Since secondary data were used for analysis, it might affect the prevalence of malaria in the study area. However, the present study showed the trend of malaria prevalence in the study area and catchment areas which provides important information to strengthen the intervention of malaria control.

Conclusion

In general, the prevalence of malaria in Wolkite health center showed a consistent downward trend from the year of 2015–2018. Plasmodium vivax seemed to be overlooked even though there were hardly any known drug resistance has been reported in the study area for P. vivax [23]. In addition, a recent randomized trial has reported the effectiveness and safety of short-course usage of Primaquine for a radical cure in P. vivax endemic areas of Ethiopia [34]. Therefore, malaria prevention and control strategy should be reinforced particularly targeting adults and rural areas and also enhancing the capacity of laboratory personnel in malaria identification is very essential to reduce the prevalence of malaria in the study area.

Availability of data and materials

The data sets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Abbreviations

WHO:

World Health Organization

GTS:

Global Technical Strategy

SOP:

Standard operating procedure

LLINs:

Long-lasting insecticide-treated nets

IRS:

Indoor residual spraying

SPSS:

Statistical Package for Social Sciences

API:

Annual parasitic incidence

NMSP:

National Malaria Strategic Plan

ACTs:

Artemisinin-based combination therapies

RBM:

Roll Back Malaria

References

  1. Tizifa TA, Kabaghe AN, McCann RS, Van den Berg H, Van Vugt M, Phiri KS. Prevention efforts for malaria. Curr Trop Med Rep. 2018;5(1):41–50. https://doi.org/10.1007/s40475-018-0133-y.

    Article  PubMed  PubMed Central  Google Scholar 

  2. World Health Organization. World malaria report 2018. Geneva: World Health Organization; 2018. https://www.who.int/malaria/publications/world-malaria-report-2018/en/ Accessed 30 July 2019.

  3. World Health Organization. Malaria: Factsheet. Geneva: World Health Organization; 2019. https://www.who.int/news-room/fact-sheets/detail/malaria Accessed 30 July 2019.

  4. Federal Democratic Republic of Ethiopia Ministry of Health. National strategic plan for malaria prevention control and elimination in Ethiopia 2011–2015. Addis Ababa: Federal Democratic Republic of Ethiopia Ministry of Health; 2010.

    Google Scholar 

  5. World Health Organization. WHO African region: Ethiopia: Malaria. Geneva: World Health Organization; 2019. https://www.iamat.org/country/ethiopia/risk/malaria Accessed 30 July 2019.

  6. President’s Malaria Initiative. Ethiopia. Malaria operational plan FY 2019; 2019.

  7. Gari T, Lindtjørn B. Reshaping the vector control strategy for malaria elimination in Ethiopia in the context of current evidence and new tools: opportunities and challenges. Malar J. 2018;17:454.

    Article  Google Scholar 

  8. Federal Democratic Republic of Ethiopia Ministry of Health. National malaria Guideline. Addis Ababa: Federal Democratic Republic of Ethiopia Ministry of Health; 2012.

    Google Scholar 

  9. Federal Democratic Republic of Ethiopia Ministry of Health. National Malaria Elimination Roadmap. Addis Ababa: Federal Democratic Republic of Ethiopia Ministry of Health; 2016. p. 1–32.

    Google Scholar 

  10. Ketema T, Getahun K, Bacha K. Therapeutic efficacy of chloroquine for treatment of Plasmodium vivax malaria cases in Halaba district, South Ethiopia. Parasit Vectors. 2011;4:46.

    Article  Google Scholar 

  11. Gurage zone Health Bureau health sector growth and transformation Annual Report 2017, Wolkite, Ethiopia; 2018.

  12. Wolkite climate data.org. https://en.climate-data.org/africa/ethiopia/southern-nations/welkite-29081/ Accessed 30 July 2019.

  13. Anmut W, Fekecha B, Demeke T. Mother’s knowledge and Practice about neonatal danger signs and associated factors in Wolkite Town, Gurage Zone, SNNPR, Ethiopia, 2017. J Biomed Sci. 2017;6(4):33.

    Google Scholar 

  14. Federal Democratic Republic of Ethiopia Population Census Commission. Summary and statistical report of the 2007 population and housing census: population size by age and sex. Addis Ababa: Central Statistics Agency; 2012.

    Google Scholar 

  15. Cheesbrough M. District laboratory practice in tropical countries. Cambridge: Cambridge University Press; 2006.

    Book  Google Scholar 

  16. Tesfa H, Bayih AG, Zeleke AJ. A 17-year trend analysis of malaria at Adi Arkay, north Gondar zone, Northwest Ethiopia. Malar J. 2018;17(1):155. https://doi.org/10.1186/s12936-018-2310-9.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Karunamoorthi K, Bekele M. Prevalence of malaria from peripheral blood smears examination: a 1-year retrospective study from the Serbo Health Center, Kersa Woreda, Ethiopia. J Infect Public Health. 2009;2(4):171–6. https://doi.org/10.1016/j.jiph.2009.08.005.

    Article  PubMed  Google Scholar 

  18. Shamebo T, Petros B. Trend analysis of malaria prevalence in Halaba special district, Southern Ethiopia. BMC Res Notes. 2019;12(1):190. https://doi.org/10.1186/s13104-019-4215-2.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Legesse D, Haji Y, Abreha S. Trend analysis of malaria occurrence in Wolaita Zone, Southern Ethiopia: retrospective cross-sectional study. Malar Res Treat. 2015. https://doi.org/10.1155/2015/123682.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Girum T, Hailemikael G, Wondimu A. Factors affecting prevention and control of malaria among endemic areas of Gurage zone: an implication for malaria elimination in South Ethiopia, 2017. Trop Dis Travel Med Vaccines. 2017;3:17.

    Article  Google Scholar 

  21. Alemu A, Abebe G, Tsegaye W, Golassa L. Climatic variables and malaria transmission dynamics in Jimma town, South West Ethiopia. Parasit Vectors. 2011;4:30.

    Article  Google Scholar 

  22. Woyessa A, Deressa W, Ali A, Lindtjørn B. Prevalence of malaria infection in Butajira area, south-central Ethiopia. Malar J. 2012;11:84.

    Article  Google Scholar 

  23. Shumbej T, Jemal A, Worku A, Bekele F, Weldesenbet H. Therapeutic efficacy of chloroquine for treatment of Plasmodium vivax malaria cases in Guragae zone southern Central Ethiopia. BMC Infect Dis. 2019;19:413. https://doi.org/10.1186/s12879-019-4055-7.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Bajoga UA, Balarabe HS, Olufemi AA, et al. Trend of malaria cases in Kaduna State using routine surveillance data, 2011–2015. Pan Afr Med J. 2019;32(Suppl 1):8. https://doi.org/10.11604/pamj.supp.2019.32.1.13735.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Gebretsadik D, Feleke DG, Fiseha M. Eight-year trend analysis of malaria prevalence in Kombolcha, South Wollo, north-central Ethiopia: a retrospective study. Parasit Vectors. 2018;11(1):55. https://doi.org/10.1186/s13071-018-2654-6.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Alemu A, Muluye D, Mihret M, Adugna M, Gebeyaw M. Ten year trend analysis of malaria prevalence in Kola Diba, North Gondar, Northwest Ethiopia. Parasit Vectors. 2012;5(1):173.

    Article  Google Scholar 

  27. Tesfay K, Yohannes M, Bayisa S. Trend analysis of malaria prevalence in Raya Azebo district, Northern Ethiopia: a retrospective study. BMC Res Notes. 2018;11(1):900. https://doi.org/10.1186/s13104-018-4003-4.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Yimer M, Hailu T, Mulu W, Abera B, Ayalew W. A 5-year trend analysis of malaria prevalence within the catchment areas of Felegehiwot Referral Hospital, Bahir Dar city, northwest-Ethiopia: a retrospective study. BMC Res Notes. 2017;10(1):239.

    Article  Google Scholar 

  29. Hailemariam M, Gebre S. Trend analysis of malaria prevalence in Arsi Negelle health center, Southern Ethiopia. J Infect Dis. 2015;7(1):1–6. https://doi.org/10.5897/JIDI2014.0147.

    Article  Google Scholar 

  30. Kibret S, Wilson GG, Ryder D, Tekie H, Petros B. Environmental and meteorological factors linked to malaria transmission around large dams at three ecological settings in Ethiopia. Malar J. 2019;18(1):54. https://doi.org/10.1186/s12936-019-2689-y.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Howes RE, Battle KE, Mendis KN, et al. Global epidemiology of Plasmodium vivax. Am J Trop Med Hyg. 2016;95(6 Suppl):15–34.

    Article  Google Scholar 

  32. Mazigo HD, Rumisha SF, Chiduo MG, Bwana VM, Mboera LE. Malaria among rice farming communities in Kilangali village, Kilosa district, Central Tanzania: prevalence, intensity, and associated factors. Infect Dis Poverty. 2017;6(1):101. https://doi.org/10.1186/s40249-017-0315-1.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Kreuels B, Kobbe R, Adjei S, et al. Spatial variation of malaria incidence in young children from a geographically homogeneous area with high endemicity. J Infect Dis. 2008;197(1):85–93.

    Article  Google Scholar 

  34. Taylor WR, Thriemer K, von Seidlein L, et al. Short-course Primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial. Lancet. 2019;394(10202):929–38.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors would like to thank Wolkite University College of Medicine and Health Sciences Research Coordinator Office, Gurage zone health bureau, staff of Wolkite health center.

Funding

Not applicable.

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to conceptual and study design, data analysis, reviewed the paper critically then gave final approval to be published and agreed to be responsible for all aspects of the work. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Absra Solomon.

Ethics declarations

Ethics approval and consent to participate

The study was reviewed and approved by the ethical and review committee of Wolkite University College of Health Science. A letter of permission to conduct the study was obtained from the Gurage zone health bureau and the health center. A Confidentiality assured for all the information gathered from the logbook by giving a unique ID number and all information was used on for this study only.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Solomon, A., Kahase, D. & Alemayehu, M. Trend of malaria prevalence in Wolkite health center: an implication towards the elimination of malaria in Ethiopia by 2030. Malar J 19, 112 (2020). https://doi.org/10.1186/s12936-020-03182-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12936-020-03182-z

Keywords